Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.6% ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

Brent Greetham has been appointed chief financial officer at Surgical Innovations, with effect from 24 February 2025. Chris ...

Recent health news highlights include Gilead's upbeat 2025 forecast, Edwards Lifesciences surpassing profit estimates, New ...

FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

Shares of Super Micro Computer jumped after the company set a sales outlook for fiscal 2026 that blows past current Wall Street forecasts, unwinding a selloff earlier in the day.

Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced key executive appointments designed to accelerate the ...

In a groundbreaking step toward sustainability and innovation in health care, Parcel Health and Allegheny Health Network (AHN) announced today a pilot program in which ...

March S&P 500 E-Mini futures (ESH25) are trending down -0.12% this morning as investors braced for the release of key U.S. inflation data while also awaiting further testimony from Federal Reserve ...

Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.